Jun. 22 at 10:57 PM
$CPHI Featured Alongside Global Pharma Leaders: According to the official Jinan government website, CPHI’s bacterial infection treatment was listed under the city’s supervised drug pricing catalogue on June 3, 2025. This inclusion means the product is now available in Jinan’s regulated public healthcare system, a city with a population of over 9 million.
In the same list, major global pharmaceutical companies are also featured:
1.
$NVS (Novartis): Complex Substitution – likely a specialty cardiovascular or metabolic drug.
2.
$BLCO (Bausch + Lomb): Runshu Eye Drops – used for eye dryness and irritation relief.
3.
$BAYRY (Bayer): Glucobay (Acarbose) – an oral medication used to treat type 2 diabetes.
4.
$SNY (Sanofi): Amlodipine (Amory) – a blood pressure and angina medication.
....and many more.
All these drug companies are expanding presence within China’s public healthcare and pharmaceutical retail network.
